Pemigatinib-Associated Psoriasis in a Patient With Cholangiocarcinoma

By afschroeder • June 9, 2026

Hendrie AG, Hadj Smaine L. Pemigatinib-Associated Psoriasis in a Patient With Cholangiocarcinoma. Cureus. 2026 May 7;18(5):e108439. doi: 10.7759/cureus.108439. PMID: 42255868; PMCID: PMC13242240.

Tags: Cholangiocarcinoma, drug-induced psoriasis, fgfr inhibitor, General Internal Medicine, pemigatinib, Primary Care, psoriasis, Publications

A Rare Case of Concurrent Chronic Lymphocytic Leukemia and Therapy-Unrelated Acute Myeloid Leukemia That Evolved From Myelodysplastic Neoplasm

Bansil S, Lai SY, Lo AE, Dietz R Jr, Reed JP. A Rare Case of Concurrent Chronic Lymphocytic Leukemia and Therapy-Unrelated Acute Myeloid Leukemia That[...]

Cytomegalovirus (CMV) Colitis Complicated by a Stricture in an Immunocompetent Adult

Pinto DS, Larios KN, Saini I. Cytomegalovirus (CMV) Colitis Complicated by a Stricture in an Immunocompetent Adult. Cureus. 2026 May 7;18(5):e108452. doi: 10.7759/cureus.108452. PMID: 42255849;[...]

Resident Physicians’ Work-Related Emotional Experiences: A Scoping Review of Qualitative Research

McLaughlin J, Nguyen K, Bromley E, Burton J, Buchbinder L, Nafisi A, Sandesara U. Resident Physicians' Work-Related Emotional Experiences: A Scoping Review of Qualitative Research.[...]